Atossa Therapeutics, Inc. ( ATOS) - Stock Earnings
ATOS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -5.5 million USD | — USD |
| 2023Q2 | -9.8 million USD | — USD |
| 2023Q3 | -6.2 million USD | — USD |
ATOS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -20.6 million USD | 0 USD |
| 2022 | -26.2 million USD | 0 USD |
| 2023 | -29.8 million USD | — USD |
ATOS
Price: $2.01
52 week price:
Earnings Per Share: -3.45 USD
P/E Ratio: -1.36
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 530800
Ebitda: -2.0 millionMarket Capitalization: 41.8 million